Jiangsu, China
Business Type:
Manufacturer/Factory & Trading Company
Number of Employees:
2921
Year of Establishment:
1995-03-28
Management System Certification:
GMP
Average Lead Time:
Peak season lead time: one month
Off season lead time: one month
OEM/ODM Service
Sample Available
Spanish Speaker

Montmorillonite, Diclofenac manufacturer / supplier in China, offering Pemetrexed Disodium for Injection, Edaravone Injection, Diosmectite Powder-EU GMP and so on.

Gold Member Since 2018
Audited Supplier
Info marked by "" is verified by SGS

Contact Supplier

Mr. Liu
Sales Manager
Watch Video
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Business Type: Manufacturer/Factory & Trading Company
Main Products: Anti-Tumor Drug , Central Nervous Drug , Anti-Infection Drug , Cardiovascular Drug , Skeletal ...
Number of Employees: 2921
Year of Establishment: 1995-03-28
Management System Certification: GMP
Average Lead Time: Peak season lead time: one month
Off season lead time: one month

Jiangsu Simcere Pharmaceutical Co., Ltd was founded on March 28, 1995 with an enterprise mission to "discover and develop high-quality medicines for patients. " Since its inception, we have grown from a registered capital of 2.78 million to total assets of over 3 billion yuan, from a few dozen people to a R&D-driven pharmaceutical enterprise with more than 3, 000 talents, and from an annual tax of less than a million to about 500 million yuan. We have ranked among "the top 100 Chinese Pharmaceutical Companies" for consecutive years, and our growth goes beyond the numbers.

To fulfill our dream, we have progressed through a string of strategic options, including but not limited to the development of first generic products, merger and acquisition, the build-up of research institute, an alliance with multinational corporations, and innovative research mechanisms.

At present, these efforts are bearing fruits:

In 2009, our montmorillonite powder product successfully passed EU GMP certification and started exporting to Europe, a milestone for ′Made in Simcere′ for global markets. Currently, we are actively implementing cGMP and EUGMP to transform all of our small molecule manufacture sites to comply with international standards.

In recent years, Simcere has established high-quality international cooperation through various partnership models. For example, we partnered with American Apexigen Company to develop an innovative anti-VEGF humanized monoclonal antibody in China. Together with Bristol-Myers Squibb, we are conducting Phase III trial for abatacept, a monoclonal antibody for treatment of rheumatoid arthritis, and so forth. These partnerships are a powerful testament to the fact that Chinese pharmaceutical companies can collaborate with multinational corporations to scale down R&D cost and accelerate R&D innovation in China. The Ministry of Science and Technology recognized our Company as an ′International Scientific and Technological Cooperation Base.

We now own over 50 products that cover Oncology, Cardiovascular and Cerebrovascular, Anti-infection, Rheumatology and other therapeutic areas. We have three products (Endostar® , Sinofuan® , Iremod® ) that were the first-to-launch in the world, and six products (BICUN® , ZAILIN® , ANTINE® , YEQING® , JIEBAISHU® , Newanti® ) that were the first-in-class in China. Since 2007, we have submitted over 200 domestic and PCT patent applications. Over 10 innovative drugs are being studied in clinical trials, which will broaden our current marketed product portfolio.

In 2015, the Ministry of Science and Technology designated one of our laboratories as the ′national key laboratory for translational medicine and innovative drugs′. Simcere ranks among the ′Top 10 Chinese Companies in Pharmaceutical Innovation′ in recent years.

SIMCERE, PIONEER THE HEALTHCARE FRONTIER.

Trade Capacity

International Commercial Terms(Incoterms):
FOB, CIF, CFR
Terms of Payment:
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
Average Lead Time:
Peak season lead time: one month, Off season lead time: one month
Number of Foreign Trading Staff:
5
Main Customer(s):
Company Name Country/Region Products You Supply
Mylan France Montmorillonite Powder
Export Year:
2010-01-01
Export Percentage:
1%~10%
Main Markets:
Europe, Domestic
Nearest Port:
Shanghai Port
Import & Export Mode:
Exportation via agency

Production Capacity

Factory Address:
No.8 Xinglong Road,Pukou Economic Development Zone,Nanjing City,Jiangsu Province,China
R&D Capacity:
Own Brand, ODM, OEM
No. of R&D Staff:
226
No. of Production Lines:
10
Annual Output Value:
Above US$100 Million
Ever Annual Output of Main Products:
Product Name Units Produced (Previous Year)
Edaravone Injection 60000000 Pieces
Pemetrexed Disodium Freeze Dried Powder for Injection 4600000 Pieces
Recombinant Human Endostatin Injection 200000 Pieces

Send your message to this supplier

*From:
*To:
avatar Mr. Liu
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now